Doctor's Bio
Dr. Bassel Nazha, MD, MPH is a medical oncologist who specializes in the treatment of genitourinary (GU) cancers. At Grady, Dr. Bassel Nazha provides care to patients at the GU medical oncology clinic. He also teaches medical students, Internal Medicine resident physicians, and Hematology/Medical oncology fellow physicians. Dr. Nazha is board-certified in Internal Medicine, Hematology, and Medical Oncology.
Board Certifications
American Board of Internal Medicine
Affiliations
Emory
Education & Training
- Medical School: American University of Beirut Medical Center
- Residency: Staten Island University Hospital
Fellowships
Emory University School of Medicine
Locations and Directions
Grady Memorial Hospital
Phone: (404) 616-1000
Location:
80 Jesse Hill Jr Drive SE
Atlanta, GA 30303
Publications
- Molecular Characterization and Clinical Outcomes of Pancreatic Neuroendocrine Neoplasms Harboring PAK4-NAMPT Alterations.
Azar I, Khan HY, Bannoura SF, Gandhi N, Uddin MH, Nagasaka M, Gong J, Nazha B, Choucair K, Vojjala N, Khushman MM, Soares HP, El-Deiry WS, Philip PA, El-Rayes B, Chen H, Lou E, Muqbil I, Farrell AP, Swensen J, Oberley MJ, Nabhan C, Goel S, Shields AF, Mohammad RM, Pasche BC, Azmi AS
JCO oncology advances. 2025;2(1):e2400032.
PMID: 40330142 - Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial.
Bilen MA, Vo BT, Liu Y, Greenwald R, Davarpanah AH, McGuire D, Shiradkar R, Li L, Midya A, Nazha B, Brown JT, Williams S, Session W, Russler G, Caulfield S, Joshi SS, Narayan VM, Filson CP, Ogan K, Kucuk O, Carthon BC, Del Balzo L, Cohen A, Boyanton A, Prokhnevska N, Cardenas MA, Sobierajska E, Jansen CS, Patil DH, Nicaise E, Osunkoya AO, Kissick HT, Master VA
Nature cancer. 2025;6(3):432-444.
PMID: 40016487 - Association of baseline inflammatory biomarkers and clinical outcomes in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitors.
Yildirim A, Wei M, Liu Y, Nazha B, Brown JT, Carthon BC, Choi Y, Suh L, Goswamy RV, McClintock GR, Hartman C, Caulfield S, Ciuro J, Goldman JM, Harris WB, Kucuk O, Master VA, Bilen MA
Therapeutic advances in medical oncology. 2025;
PMID: 39943944 - Real-World Outcomes in Patients with Advanced Penile Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Single Institution Experience.
Zhuang TZ, Goyal S, Case KB, Olsen TA, Vemuru S, Yildirim A, Goswamy RV, Brown JT, Carthon BC, Kucuk O, Bilen MA, Master VA, Nazha B
Journal of immunotherapy and precision oncology. 2025;8(1):1-10.
PMID: 39811423 - Characteristics, Treatment, and Outcomes of Primary Urethral Cancer: A Multicenter Review Over Two Decades.
Hopkins BD, Qian DC, Xu KM, McCook-Veal A, Switchenko J, Hartsell LM, Cimmino CB, Joshi SS, Narayan V, Master VA, Nazha B, Carthon BC, Bilen MA, Kucuk O, Shelton JW, Patel PR, Jani AB, Remick JS, Eng TY
Clinical genitourinary cancer. 2025;23(1):102276.
PMID: 39709687 - Trop-2 and Ephrin B2 expression in urothelial carcinoma with divergent differentiation and aggressive urothelial carcinoma subtypes.
Case KB, Martini DJ, Dababneh MN, Bidot S, Nazha B, Brown J, Joshi S, Narayan V, Parihar V, Saeed F, Bilen MA, Harik LR
American journal of clinical pathology. 2025;163(4):618-628.
PMID: 39705501 - Neoadjuvant cabozantinib restores CD8+ T cells in patients with locally advanced non-metastatic clear cell renal cell carcinoma: a phase 2 trial.
Bilen MA, Vo BT, Liu Y, Greenwald R, Davarpanah AH, McGuire D, Shiradkar R, Li L, Nazha B, Brown JT, Williams S, Session W, Russler G, Caulfield S, Joshi SS, Narayan VM, Filson CP, Ogan K, Kucuk O, Carthon BC, Del Balzo L, Cohen A, Boyanton A, Prokhnevska N, Cardenas MA, Sobierajska E, Jansen CS, Patil DH, Nicaise E, Osunkoya AO, Kissick H, Master VA
Research square. 2024;
PMID: 39149474 - PD-L1 and nectin-4 expression and genomic characterization of bladder cancer with divergent differentiation.
Martini DJ, Case KB, Gratz D, Pellegrini K, Beagle E, Schneider T, Dababneh M, Nazha B, Brown JT, Joshi SS, Narayan VM, Ogan K, Master VA, Carthon BC, Kucuk O, Harik LR, Bilen MA
Cancer. 2024;130(21):3658-3670.
PMID: 38959291 - The Evolving Landscape of Biomarkers for Immune Checkpoint Blockade in Genitourinary Cancers.
Seema Mustafa , Jansen CS, Jani Y, Evans S, Zhuang TZ, Brown J, Nazha B, Master V, Bilen MA
Biomarker insights. 2024;
PMID: 38827239 - Billing for Electronic Patient-Physician Communications: An Ethical Analysis.
Rhee CH, Brown JT, Lang A, Pentz RD, Nazha B
JCO oncology practice. 2024;20(8):1040-1045.
PMID: 38593382
PLANNING
PREPARING FOR YOUR VISIT
Whether you’re a patient or you’re visiting one, a little planning beforehand can make your visit to Grady easier and more comfortable. Here, you’ll find everything you need to prepare for your visit, including an appointment checklist, admissions information, dining options, and much more.